QIAstat-Dx Respiratory SARS-CoV-2 Panel
- QIAstat-Dx Respiratory SARS-CoV-2 Panel is authorized by FDA under an Emergency Use Authorization (EUA)
- Enables detection of the SARS-CoV-2 virus that causes COVID-19 in addition to 20 other respiratory pathogens
- Intuitive workflow with less than one-minute hands-on time
- All wet and dry reagents onboard and room temperature stable
- Comprehensive qualitative results available in about an hour
To support the efforts for acessible testing to meet the demands of the COVID-19 outbreak, QIAGEN developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge detects and differentiates* 21 respiratory targets, including SARS-CoV-2 from nasopharyngeal swabs (NPS) eluted in universal transport media (UTM).
The QIAstat-Dx Analyzer, combined with QIAstat-Dx assay cartridges, uses real-time PCR to detect pathogen nucleic acids in human biological samples. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that contains on board all necessary reagents, enabling hands-off sample preparation. Detected real-time amplification signals are interpreted by the integrated software and are reported via an intuitive user interface.
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is for in vitro diagnostic use under Emergency Use Authorization (EUA) only. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity and moderate complexity tests.
The QIAstat-Dx Respiratory SARS-CoV-2 Panel has not been FDA cleared or approved;
The QIAstat-Dx Respiratory SARS-CoV-2 Panel has been authorized by FDA under an EUA for use by authorized laboratories;
The QIAstat-Dx Respiratory SARS-CoV-2 Panel has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms; and
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
* Enterovirus and Rhinovirus are both detected, but not differentiated, with the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
- Buy Products
- Product Details
Buy Products
Cat No./ID:691223 QIAstat-Dx Respiratory SARS-CoV-2 Panel Inquire 6 individually packaged cartridges containing all reagents needed for sample preparation and multiplex RT-real time PCR plus internal control, including 6 transfer pipettes |
Cat No./ID:9002813 QIAstat-Dx Operational Module Inquire Module enables interaction with the QIAstat-Dx Analyzer. |
Cat No./ID:9002814 QIAstat-Dx Analytical Module Inquire Module contains the hardware and software for sample testing and analysis. |
Cat No./ID:9002824 QIAstat-Dx Analyzer Inquire Instrument consists of both the Operational Module and Analytical Module. |
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is for in vitro diagnostic use under Emergency Use Authorization (EUA) only. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity and moderate complexity tests.
Product Details
The Limit of Detection (LOD) value obtained for the SARS-CoV-2 target tested with the QIAstat-Dx Respiratory SARS-CoV-2 Panel.
| Pathogen | Strain | Source | Concentration | Detection rate |
| SARS-CoV-2 | Clinical Sample | Hospital from Barcelona, Spain | 500 copies/mL | 20/20 |
The performance of SARS-CoV-2 target in the QIAstat-Dx Respiratory SARS-CoV-2 Panel was evaluated using retrospective nasopharyngeal swab clinical specimens in transport medium.
| SARS-CoV-2 Targets | ||||||
| Sample | Sample type | N | % positive | (95% Cl) | % Negative | (95%Cl) |
| Positives | Positive clinical sample | 10 | (10/10) 100% | N/A | 0/0 | N/A |
| Low positive contrived sample (1x–2x LOD) | 20 | (20/20) 100% | N/A | 0/0 | N/A | |
| Total Positive Samples | 30 | (30/30) 100% | 85.8–100% | 0/0 | N/A | |
| Negative | Total Negative Samples | 30 | 0/0 | N/A | (30/30) 100% | 85.8–100% |
QIAstat-Dx Respiratory SARS-CoV-2 Panel Intended Use
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is a multiplexed nucleic acid real-time PCR test intended for the qualitative detection and differentiation of nucleic acid from multiple respiratory viral and bacterial organisms, including the SARS-CoV-2 virus, in nasopharyngeal swabs (NPS) eluted in universal transport media collected from patients suspected of COVID 19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity and moderate complexity tests.
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is intended for the detection and differentiation of nucleic acid from SARS-CoV-2 and the following organism types and subtypes: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, SARS-CoV-2, Human Metapneumovirus A+B, Influenza A, Influenza A H1, Influenza A H3, Influenza A H1N1/pdm09, Influenza B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, Respiratory Syncytial Virus A+B, Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.
SARS-CoV-2 RNA and nucleic acids from the other respiratory viral and bacterial organisms identified by this test are generally detectable in nasopharyngeal swabs (NPS) during the acute phase of infection. Positive results are indicative of the presence of the identified microorganism, but do not rule out co-infection with other pathogens not detected by the test, or lower respiratory tract infection that is not detected by a nasopharyngeal swab. The agent detected may not be the definite cause of disease.
For SARS-CoV-2 positive specimens; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Laboratories within the United States and its territories are required to report all SARS-CoV-2 positive results to the appropriate public health authorities.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or other patient management decisions. Negative SARS-CoV-2 results must be combined with clinical observations, patient history, and epidemiological information. Negative results for other organisms identified by the test may require additional laboratory testing (eg, bacterial and viral culture, immunofluorescence and radiography) when evaluating a patient with possible respiratory tract infection.
Testing with the QIAsta-Dx Respiratory SARS-CoV-2 Panel is intended for use by qualified and trained operators who are proficient in performing the tests using the QIAstat-Dx Analyzer System. The QIAstat-Dx Respiratory SARS-CoV-2 Panel is only for use under the Food and Drug Administration’s Emergency Use Authorization.
Product Resources
Customers who bought these products also bought
- Cat No./ID:61704
QIAamp DSP Virus Spin Kit
For 50 preps: QIAamp MinElute Spin Columns, Buffers, Reagents, and Tubes$311.00Add To Cart - Cat No./ID:622130
QuantiFERON-TB Gold Plus 2 Plate ELISA Kit
2 sets of 12 x 8 Microplate Strips; IFN-gamma Standard, lyophilized; Green Diluent; Conjugate 100x Concentrate, lyophilized; Wash Buffer 20x Concentrate; Enzyme Substrate Solution; Enzyme Stopping Solution$775.00Add To Cart - Cat No./ID:990382
Sample Tubes CB (2 ml)
1000 conical screw-cap tubes without skirted base (2 ml) for use with the QIAcube and QIAcube Connect$71.70Add To Cart - Cat No./ID:691212
QIAstat-Dx Respiratory 2019-nCoV Panel
Six individually packaged cartridges containing all reagents needed for sample preparation and multiplex real-time PCR plus internal control, including six transfer pipettes
Add To Cart - Cat No./ID:1068337
Carrier RNA (Poly rA) (310µg)
Carrier RNA (Poly rA) (310µg)$114.00Add To Cart - Cat No./ID:622536
QuantiFERON-TB Gold Plus Blood Collection Tubes
200 QFT-Plus Blood Collection Tubes (50 each:Nil, TB1, TB2 andMitogen tubes)$1,499.00Add To Cart - Cat No./ID:691411
QIAstat-Dx Gastrointestinal Panel
6 individually packaged cartridges containing all reagents needed for sample preparation and multiplex RT-real time PCR plus internal control, including 6 transfer pipettes
Add To Cart - Cat No./ID:990394
Rotor Adapters (10 x 24)
For 240 preps: 240 Disposable Rotor Adapters and 240 Elution Tubes (1.5 ml); for use with the QIAcube$45.60Add To Cart - Cat No./ID:9018306
EZ1 Advanced DSP Virus Card
Preprogrammed card for EZ1 DSP Virus protocol$821.00Add To Cart - Cat No./ID:981103
Strip Tubes and Caps, 0.1 ml (250)
250 strips of 4 tubes and caps for 1000 reactions of 10–50 µl$250.00Add To Cart - Cat No./ID:691211
QIAstat-Dx Respiratory Panel V2
6 individually packaged cartridges containing all reagents needed for sample preparation and multiplex RT-real time PCR plus internal control, including 6 transfer pipettes
Add To Cart - Cat No./ID:981005
PCR Tubes, 0.2 ml (1000)
1000 thin-walled tubes for 1000 reactions of 20–50 µl$162.00Add To Cart - Cat No./ID:990332
Filter-Tips, 200 µl, (1024)
Disposable Filter-Tips, racked; (8 x 128). For use with the QIAcube and the QIAsymphony SP/AS instruments$104.00Add To Cart - Cat No./ID:990352
Filter-Tips, 1000 µl (1024)
Disposable Filter-Tips, racked; (8 x 128). For use with the QIAcube$105.00Add To Cart - Cat No./ID:52906
QIAamp Viral RNA Mini Kit (250)
IMPORTANT: Packaging of this kit is optimized for the global fight against COVID19 caused by the coronavirus (SARS-CoV-2). Only kit format available is 250 prep version. See Important Note for details.
For 250 RNA preps: 250 QIAamp Mini Spin Columns, Carrier RNA, Collection Tubes (2 ml), RNase-free buffers
$1,170.00Add To Cart - Cat No./ID:9018896
Rotor-Disc 100 Locking Ring
For locking a Rotor-Disc 100 in the Rotor-Disc 100 Rotor$333.00Add To Cart - Cat No./ID:9018895
Rotor-Disc 100 Rotor
For holding Rotor-Disc 100 discs with reaction volumes of 15–25 µl in the Rotor-Gene Q; requires Rotor-Disc 100 Locking Ring$553.00Add To Cart
